This position supports the Director, International Market Access & Pricing – Migraine, in developing access strategies and key deliverables for the Prevention of Migraine and Menstrual Migraine indications.

For the prevention indication, the focus will be on partnering with Area and Affiliate teams to secure access in markets where it has not yet been achieved and to improve access where Aquipta has already launched. The Menstrual Migraine indication represents an exciting new chapter for Aquipta; here, the role will focus on launch preparation, working with cross-functional teams on launch strategy, launch readiness and the approach to securing access.

• This role will leverage your clinical understanding, deep global payer knowledge and competitive insights to shape Access deliverables for Aquipta (atogepant).
• The position works closely with Area and Affiliate teams to determine appropriate responses and actions at key development milestones, with regard to their implications for local pricing and reimbursement.
• The primary goal of this position is to define and refine the international pricing and access strategy, and to influence the global commercial strategy and integrated evidence programme, in order to optimise price, reimbursement and patient access for Aquipta.

Overall Responsibilities Include:

• Assessing and addressing pricing, reimbursement and access (PRA) potential across key international markets, including the EU5, Canada, Japan, Australia, Brazil and China
• Co-leading, with the Director, International Market Access & Pricing – Migraine, the Value and Access Team (VAT) through the creation and roll-out of the Integrated Access Strategy (IAS) for Menstrual Migraine, leveraging evidence-based medicine expertise, clinical background, deep global payer knowledge, research and competitive insights
• Working with cross-functional stakeholders, such as IMCO, Medical Affairs and Government Affairs, to shape the brand plan, and acting as a key contributor to an AbbVie migraine platform launching in 2027
• Updating international access materials (e.g. IAS, value proposition, payer objection handler and negotiation pathway) based on market insights and competitor dynamics
• Collaborating with other iMAP functions, such as Pricing and HTA Strategy, as well as GHEOR, MABI, Government Affairs, IMCO, Pipeline Commercial Development, Medical Affairs and complementary Area and Affiliate functions, to ensure a solid understanding of global payer markets and emerging reimbursement stakeholders
• Leading project management, including purchasing support and the opening of POs, and ensuring appropriate project documentation is in place and stored in line with company procedures